News

Antimicrobial resistance (AMR) presents a worldwide challenge, disproportionately impacting the least developed nations. There is an urgent need to find innovative strategies to expand access to available antibiotics for conditions of high medical need in these geographies.

The Pediatric Praziquantel Consortium, which Lygature proudly coordinates, has announced an important new milestone: The European Medicines Agency (EMA) has adopted a positive scientific opinion of the Consortium’s new pediatric treatment option for preschool-aged children with schistosomiasis.

The European Lead Factory (ELF), a flagship open innovation platform focused on finding high-quality leads for new drug discovery programs, has officially come to a close. 

Lygature is proud to announce that Denis Groot, Finance Director at Lygature, will join the Board of Trustees of EUPATI Europe as treasurer. 

In October 2023, the Netherlands launched the Dutch COVID-19 Data Portal and connected it to the existing network of COVID-19 Data Portals. 

What should you know about the upcoming IHI calls? In this article, Wim-Jan Koot, Business Director at Lygature, discusses key points to be aware of before you submit a proposal.

On 9 November, the second edition of Lygature’s stakeholder event Lygature LIVE took place at Villa Jongerius in Utrecht. The topic of this year’s Lygature LIVE was ‘All Inclusive Innovation’ and focused on inclusion and diversity in partnerships: how do you make sure all stakeholders are fairly represented at the right time?

In 2023, more than 7 million people are living with dementia in the European Union. This number is projected to double, reaching 14 million in 2050. This will create a huge burden on healthcare systems, both in terms of human and financial resources. There is currently no cure for Alzheimer's disease.

UNITE4TB, an international public-private partnership, which Lygature is proud to be a partner of, has  announced the start of its Phase 2B/C clinical trial program. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered. 

Next week, on Thursday 9 November, Lygature will organize the second edition of Lygature LIVE. The event will take place at Villa Jongerius in Utrecht, from 15:00-20:00 and includes dinner.

Mirjam Mol-Arts and Jan Smit have joined the Board of Directors of the Lygature foundation. 

What is the potential of digital technologies such as wearables, sensors, mobile apps and cameras to improve the assessment of Alzheimer’s disease?

The process of identifying the type of brain tumor a patient has normally takes a week. Thanks to new AI technology, it’s possible to analyze this during surgery, within 1.5 hours. The new technology allows neurosurgeons to adjust their surgical strategies on the spot.

Two of Lygature’s program managers attended a Summer School in Italy about digital innovations in patient mobility. It turned out to be an inspiring as much as a fun experience.

Utrecht, 8 September 2023 - Cancer is one of the most significant health challenges of our time. It remains a challenge to provide every cancer patient with the right treatment. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, ensuring the patient is at the heart of the process.